Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: environment

Diet, Microbes & Inflammation: Unique Microbial Genetic Strains in Inflammatory Disease, Plus a Possible Arthritis Diet

Susan Bernstein  |  March 4, 2021

Experts at ACR Convergence 2020 addressed how diet & the body’s microbiome affect chronic diseases.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2020Dietgut microbiotainflammationMicrobiome

Pressmaster / shutterstock.com

What Happens When Patients Have Access to Their Clinician’s Notes?

Ruth Jessen Hickman, MD  |  February 18, 2021

Navigating the healthcare system and its processes can seem overwhelming to patients. If patients understand why their clinician recommended something, know how and when to take medications, and why they shouldn’t skip a dose—or 10—they may not feel so out of control. Sharing examination notes with patients can be helpful to many patients who struggle…

Filed under:EMRsPatient PerspectivePractice Support Tagged with:Medical RecordsOpenNotes

Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

William J. Scheuing, MD, Nitasha Kumar, MD, William Davis, MD, & Robert Quinet, MD  |  February 16, 2021

Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus.  Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, sero­sitis, myalgias and/or hepatomegaly. Features…

Filed under:ConditionsVasculitis Tagged with:ANCA-Associated Vasculitiscase reporthydralazinepulmonary-renal syndrome

The Character of Rheumatology Has Changed Over the Past 50 Years

Bruce Rothschild, MD  |  February 16, 2021

Camelot allegedly existed once upon a time in South Wales. The name was evoked again in the 1960s, but perhaps it is also applicable to the character of rheuma­tology in the halcyon days of the 1970s and 80s.  That’s not to belittle the world we now live in, with so many treatment options for our…

Filed under:OpinionQuality Assurance/ImprovementSpeak Out Rheum Tagged with:imagingphysical examSpeak Out RheumatologyTesting

What to Expect in State Legislatures in 2021

Joseph Cantrell, JD  |  January 25, 2021

New state legislatures face many continuing issues, including budget shortfalls, vaccine distribution problems and strained healthcare infrastructure. However, opportunities exist for significant policy wins for rheumatology, particularly on the issues of step therapy reform, telemedicine and copay accumulators.

Filed under:Legislation & Advocacy Tagged with:copay accumulatorsLegislation & Advocacystep therapy reform legislationtelemedicine

B Cell Depletion: The Latest Information on Disease Processes, Therapies

Lara C. Pullen, PhD  |  January 25, 2021

Experts discussed the latest knowledge on B cell disease processes, and what it might mean for future B cell depletion therapies.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2020B cell depletionB cells

Tell a Convincing Story: Tips from the Experts on How to Secure Research Grants

Thomas R. Collins  |  January 22, 2021

Speakers at ACR Convergence 2020 offered a range of tips to navigate the competitive environment of research funding, emphasizing the importance of collaboration, diversifying funding sources and staying determined in the face of disappointment.

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2020John PeymanKaren CostenbaderNIH research fundingResearch FundingWilliam Robinson

Tips for Addressing Leg Length Discrepancy in Osteoarthritis

Abdollah Shams-Pirzadeh, MD, PA, FACR, & Kimberly Retzlaff  |  January 20, 2021

Humans are not perfectly symmetrical. Almost everyone has one ear that’s higher or one foot that’s larger than the other. Similarly, leg lengths are often not quite the same. There is disagreement as to what constitutes a clinically significant difference, but some studies suggest that leg length discrepancy (LLD) can lead to osteoarthritis (OA) of…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:leg-length discrepancy (LLD)

Winter 2021’s Awards, Appointments & Announcements in Rheumatology

Gretchen Henkel  |  January 19, 2021

New Appointments for Carlos Lozada, MD In the midst of the coronavirus pandemic, Carlos J. Lozada, MD, FACP, FACR, professor of clinical medicine, University of Miami Miller School of Medicine, has expanded his professional and volunteer duties. In May he was appointed chief (interim) of the Division of Rheumatology at the Miller School of Medicine,…

Filed under:AwardsProfiles Tagged with:Dr. Carlos J. LozadaDr. Salahuddin (Dino) KaziMovers & Shakers

whiteMocca / shutterstock.com

Virtual Reality Therapy Is Feasible for Rheumatology Patients

Ruth Jessen Hickman, MD  |  January 19, 2021

A recent pilot study explores the feasibility of virtual reality-based pain interventions for people with rheumatic con­ditions.1 Although the work is in its early stages, it may someday represent a new non-pharmacological tool for patients with chronic pain. VR for Treatment R. Swamy Venuturupalli, MD, FACR, is an associate clinical professor of medicine at the…

Filed under:ConditionsPain SyndromesResearch Rheum Tagged with:Chronic painmeditationPain ManagementTechnologyvirtual reality

  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 102
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences